Keratin hydrogel carrier system for simultaneous delivery of exogenous growth factors and muscle progenitor cells

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 104, Issue 5, 2016, Pages 864-879

  Tomblyn, Seth ^a   Pettit Kneller, Elizabeth L ^a   Walker, Stephen J ^b   Ellenburg, Mary D ^a   Kowalczewski, Christine J ^c,d   Van Dyke, Mark ^c   Burnett, Luke ^a   Saul, Justin M ^d  

^a KeraNetics LLC   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Medical Center Boulevard   (United States)

^d MIAMI UNIVERSITY   (United States)

Author keywords

controlled release; growth factor; hydrogel; regenerative medicine; tissue engineering

Indexed keywords

AMINO ACIDS; CELL ENGINEERING; CELLS; COLLAGEN; CYTOLOGY; KERATIN; MAMMALS; MUSCLE; TISSUE; TISSUE ENGINEERING;

CONTROLLED RELEASE; COVALENT CROSSLINKING; GROWTH FACTOR; INFLAMMATORY RESPONSE; MATERIAL CHARACTERISTICS; MULTINUCLEATED CELLS; MUSCLE PROGENITOR CELLS; REGENERATIVE MEDICINE;

HYDROGELS;

COLLAGEN; DRUG CARRIER; FIBROBLAST GROWTH FACTOR 2; KERATIN; SOMATOMEDIN C; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; DOWN REGULATION; DRUG DELIVERY SYSTEM; HAIR; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE STEM CELL; MYOBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SECRETION; VASCULARIZATION;

EID: 84976474779     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33438     Document Type: Article

References (65)

1. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241–1246.
2. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023–2030.
3. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007;31:729–734.
4. Fagerholm P, Lagali NS, Ong JA, Merrett K, Jackson WB, Polarek JW, Suuronen EJ, Liu Y, Brunette I, Griffith M. Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. Biomaterials 2014;35:2420–2427.
5. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729–1734.
6. Sharma B, Fermanian S, Gibson M, Unterman S, Herzka DA, Cascio B, Coburn J, Hui AY, Marcus N, Gold GE, Elisseeff JH. Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci Transl Med 2013;5:167ra6.
7. Waterman BR, Schoenfeld AJ, Holland CA, Goodman GP, Belmont PJ Jr. Burden of musculoskeletal disease and nonbattle nontraumatic injury in both war and disaster zones. J Surg Orthop Adv 2011;20:23–29.
8. United States Bone and Joint Initiative. Burden of Musculoskeletal Disease Overview. The Burden of Musculoskeletal Diseases in the United States: Prevalence, Societal and Economic Cost. Second Edition, Rosemont, IL.: American Academy of Orthopaedic Surgeons; 2011. pp 1–20.
9. United States Bone and Joint Initiative. Burden of Musculoskeletal Disease: Injuries. Second Edition, Rosemont, IL.: American Academy of Orthopaedic Surgeons; 2011. pp 129–179.
10. Mase VJ Jr, Hsu JR, Wolf SE, Wenke JC, Baer DG, Owens J, Badylak SF, Walters TJ. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 2010;33:511.
11. Corona BT, Garg K, Ward CL, McDaniel JS, Walters TJ, Rathbone CR. Autologous minced muscle grafts: A tissue engineering therapy for the volumetric loss of skeletal muscle. Am J Physiol Cell Physiol 2013;305:C761–C775.
12. Machingal MA, Corona BT, Walters TJ, Kesireddy V, Koval CN, Dannahower A, Zhao W, Yoo JJ, Christ GJ. A tissue-engineered muscle repair construct for functional restoration of an irrecoverable muscle injury in a murine model. Tissue Eng Part A 2011;17:2291–2303.
13. Tamada Y, Ikada Y. Fibroblast growth on polymer surfaces and biosynthesis of collagen. J Biomed Mater Res 1994;28:783–789.
14. Delaittre G, Greiner AM, Pauloehrl T, Bastmeyer M, Barner-Kowollik C. Chemical approaches to synthetic polymer surface biofunctionalization for targeted cell adhesion using small binding motifs. Soft Matter 2012;8:7323–7347.
15. Mariner PD, Wudel JM, Miller DE, Genova EE, Streubel SO, Anseth KS. Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical-sized calvaria bone defects in rats. J Orthop Res 2013;31:401–406.
16. Khetan S, Guvendiren M, Legant WR, Cohen DM, Chen CS, Burdick JA. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat Mater 2013;12:458–465.
17. Singh A, Zhan JA, Ye ZY, Elisseeff JH. Modular multifunctional poly(ethylene glycol) hydrogels for stem cell differentiation. Adv Funct Mater 2013;23:575–582.
18. Kolb CM, Pierce LM, Roofe SB. Biocompatibility comparison of novel soft tissue implants vs. commonly used biomaterials in a pig model. Otolaryngol Head Neck Surg 2012;147:456–461.
19. Bostman OM. Intense granulomatous inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures. Clin Orthop Relat Res 1992;278:193–199.
20. Taylor MS, Daniels AU, Andriano KP, Heller J. Six bioabsorbable polymers: In vitro acute toxicity of accumulated degradation products. J Appl Biomater 1994;5:151–157.
21. Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 2002;60:217–223.
22. Jeong SI, Jeon O, Krebs MD, Hill MC, Alsberg E. Biodegradable photo-crosslinked alginate nanofibre scaffolds with tuneable physical properties, cell adhesivity and growth factor release. Eur Cells Mater 2012;24:331–343.
23. Heino J. The collagen family members as cell adhesion proteins. Bioessays 2007;29:1001–1010.
24. Aumailley M, Timpl R. Attachment of cells to basement membrane collagen type IV. J Cell Biol 1986;103:1569–1575.
25. Zeeman R, Dijkstra PJ, van Wachem PB, van Luyn MJ, Hendriks M, Cahalan PT, Feijen J. Successive epoxy and carbodiimide cross-linking of dermal sheep collagen. Biomaterials 1999;20:921–931.
26. Wang Y, Zhang L, Hu M, Wen W, Xiao H, Niu Y. Effect of chondroitin sulfate modification on rhBMP-2 release kinetics from collagen delivery system. J Biomed Mater Res A 2010;92:693–701.
27. Parenteau-Bareil R, Gauvin R, Cliche S, Gariepy C, Germain L, Berthod F. Comparative study of bovine, porcine and avian collagens for the production of a tissue engineered dermis. Acta Biomater 2011;7:3757–3765.
28. Friess W. Collagen–biomaterial for drug delivery. Eur J Pharm Biopharm 1998;45:113–136.
29. Lin YC, Ramadan M, Hronik-Tupaj M, Kaplan DL, Philips BJ, Sivak W, Rubin JP, Marra KG. Spatially controlled delivery of neurotrophic factors in silk fibroin-based nerve conduits for peripheral nerve repair. Ann Plast Surg 2011;67:147–155.
30. Linnes MP, Ratner BD, Giachelli CM. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007;28:5298–5306.
31. Daamen WF, Veerkamp JH, van Hest JC, van Kuppevelt TH. Elastin as a biomaterial for tissue engineering. Biomaterials 2007;28:4378–4398.
32. Chien KB, Aguado BA, Bryce PJ, Shah RN. In vivo acute and humoral response to three-dimensional porous soy protein scaffolds. Acta Biomater 2013;9:8983–8990.
33. Tachibana A, Furuta Y, Takeshima H, Tanabe T, Yamauchi K. Fabrication of wool keratin sponge scaffolds for long-term cell cultivation. J Biotechnol 2002;93:165–170.
34. Richter JR, de Guzman RC, Van Dyke ME. Mechanisms of hepatocyte attachment to keratin biomaterials. Biomaterials 2011;32:7555–7561.
35. Kowalczewski CJ, Tombyln S, Wasnick DC, Hughes MR, Ellenburg MD, Callahan MF, Smith TL, Van Dyke ME, Burnett LR, Saul JM. Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials. Biomaterials 2014;35:3220–3228.
36. Saul JM, Ellenburg MD, de Guzman RC, Van Dyke M. Keratin hydrogels support the sustained release of bioactive ciprofloxacin. J Biomed Mater Res Part A 2011;98:544–553.
37. Sierpinski P, Garrett J, Ma J, Apel P, Klorig D, Smith T, Koman LA, Atala A, Van Dyke M. The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves. Biomaterials 2008;29:118–128.
38. Apel PJ, Garrett JP, Sierpinski P, Ma J, Atala A, Smith TL, Koman LA, Van Dyke ME. Peripheral nerve regeneration using a keratin-based scaffold: Long-term functional and histological outcomes in a mouse model. J Hand Surg 2008;33:1541–1547.
39. Lin YC, Ramadan M, Van Dyke M, Kokai LE, Philips BJ, Rubin JP, Marra KG. Keratin gel filler for peripheral nerve repair in a rodent sciatic nerve injury model. Plast Reconstr Surg 2012;129:67–78.
40. Hill PS, Apel PJ, Barnwell J, Smith T, Koman LA, Atala A, Van Dyke M. Repair of peripheral nerve defects in rabbits using keratin hydrogel scaffolds. Tissue Eng Part A 2011;17:1499–1505.
41. Dias GJ, Peplow PV, McLaughlin A, Teixeira F, Kelly RJ. Biocompatibility and osseointegration of reconstituted keratin in an ovine model. J Biomed Mater Res A 2010;92:513–520.
42. Thilagar S, Jothi NA, Omar AR, Kamaruddin MY, Ganabadi S. Effect of keratin-gelatin and bFGF-gelatin composite film as a sandwich layer for full-thickness skin mesh graft in experimental dogs. J Biomed Mater Res B Appl Biomater 2009;88:12–16.
43. Shen D, Wang X, Zhang L, Zhao X, Li J, Cheng K, Zhang J. The amelioration of cardiac dysfunction after myocardial infarction by the injection of keratin biomaterials derived from human hair. Biomaterials 2011;32:9290–9299.
44. Cardamone JM, Nunez A, Garcia RA, Aldema-Ramos M. Characterizing wool keratin. Res Lett Mater Sci 2009;2009:1–5.
45. Katoh K, Shibayama M, Tanabe T, Yamauchi K. Preparation and physicochemical properties of compression-molded keratin films. Biomaterials 2004;25:2265–2272.
46. Reddy N, Jiang Q, Jin E, Shi Z, Hou X, Yang Y. Bio-thermoplastics from grafted chicken feathers for potential biomedical applications. Colloids Surf B Biointerfaces 2013;110:51–58.
47. Rouse JG, Van Dyke ME. A review of keratin-based biomaterials for biomedical applications. Materials 2010;3:999–1014.
48. Reichl S. Films based on human hair keratin as substrates for cell culture and tissue engineering. Biomaterials 2009;30:6854–6866.
49. Crewther WG, Fraser RD, Lennox FG, Lindley H. The chemistry of keratins. Adv Protein Chem 1965;20:191–346.
50. de Guzman RC, Merrill MR, Richter JR, Hamzi RI, Greengauz-Roberts OK, Van Dyke ME. Mechanical and biological properties of keratose biomaterials. Biomaterials 2011;32:8205–8217.
51. Hill P, Brantley H, Van Dyke M. Some properties of keratin biomaterials: Kerateines. Biomaterials 2010;31:585–593.
52. de Guzman RC, Saul JM, Ellenburg MD, Merrill MR, Coan HB, Smith TL, Van Dyke ME. Bone regeneration with BMP-2 delivered from keratose scaffolds. Biomaterials 2013;34:1644–1656.
53. Corona BT, Machingal MA, Criswell T, Vadhavkar M, Dannahower AC, Bergman C, Zhao W, Christ GJ. Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury. Tissue Eng Part A 2012;18:1213–1228.
54. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P, Capogrossi MC. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003;163:1417–1428.
55. Anderson JE, Mitchell CM, McGeachie JK, Grounds MD. The time course of basic fibroblast growth factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice. Exp Cell Res 1995;216:325–334.
56. Dubay DA, Wang X, Kuhn MA, Robson MC, Franz MG. The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg 2004;240:179–186.
57. Fu X, Cuevas P, Gimenez-Gallego G, Tian H, Sheng Z. Ischemia and reperfusion reduce the endogenous basic fibroblast growth factor (bF GF) in rat skeletal muscles. Chinese Med J 1995;108:699–703.
58. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998;95:15603–15607.
59. Gehrig SM, van der Poel C, Hoeflich A, Naim T, Lynch GS, Metzger F. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy. Growth Horm IGF Res 2012;22:69–75.
60. Jacquemin V, Furling D, Bigot A, Butler-Browne GS, Mouly V. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp Cell Res 2004;299:148–158.
61. Grillet AM, Wyatt NB, Gloe LM. Polymer gel rheology and adhesion. In: De Vicente J, editor. Rheology. Rijeka, Croatio: InTech; 2012. pp 59–80.
62. Picout DR, Ross-Murphy SB. Rheology of biopolymer solutions and gels. Sci World J 2003;3:105–121.
63. Cilurzo F, Selmin F, Aluigi A, Bellosta S. Regenerated keratin proteins as potential biomaterial for drug delivery. Polym Adv Technol 2013;24:1025–1028.
64. Gillespie JM. The fractionation of S-carboxymethyl kerateine 2 from wool. Aust J Biol Sci 1956;10:105–117.
65. Tannoury CA, An HS. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J 2014;14:552–559.